Insights
Big plans for Little Green Pharma
Read more on the Australian firm hoping to help more UK patients benefit from medical cannabis.
Apr 2020
Export licence approved
Company news
01 Jan 2019
Little Green Pharma is pleased to announce the company has been granted an Export Licence by the Federal Department of Health, effective 15 January 2019. Obtaining this license meets one of Little Green Pharma’s key strategic milestones on the path to become a key domestic and international supplier of medical cannabis products.
Managing Director, Fleta Solomon believes the strict growing and manufacturing conditions applicable to local suppliers will ultimately give Australian medical cannabis the edge over international competitors, many of which are subject to less stringent quality and manufacturing standards.
Little Green Pharma’s goal is to make clean and natural, Australian-grown and medical grade medical cannabis products to supply both the Australian and overseas markets in 2019.
You might also be interested in
Insights
Phoney websites/employment scams
Little Green Pharma would like to alert website users to be aware of phoney websites and accompanying internet “scams” such as “phishing” and other techniques designed to trick people into giving out their personal information.
Oct 2020
Insights
Little Green Pharma to commence trading on ASX 20 February
Little Green Pharma raised the maximum subscription amount of $10 million in an oversubscribed IPO.
Feb 2020